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httpManagement strategy for spontaneous isolated
dissection of the superior mesenteric artery based
on morphologic classiﬁcation
Dong-lin Li, MD,a Yang-yan He, MD,a Adel M. Alkalei, MD,a Xu-dong Chen, MD,a Wei Jin, MD,a
Ming Li, MD,a Hong-kun Zhang, MD, PhD,a and Ting-bo Liang, MD, PhD,b Hangzhou, China
Objective: To explore a therapy strategy for the spontaneous isolated dissection of the superior mesenteric artery
(SIDSMA) based on morphologic classiﬁcation.
Methods: Forty-two symptomatic patients with SIDSMA presenting with abdominal pain between January 2007 and
December 2012 were enrolled in this retrospective study. We proposed a new morphologic classiﬁcation with subtypes
depending on the patency of the true lumen and reviewed the patients’ clinical features, risk factors, computed tomog-
raphy images (morphologic classiﬁcation, location of entry site, dissection length, and true lumen residual diameter),
treatment modalities, and follow-up results.
Results: Twenty-four patients received only observation treatment, seven received open surgery, and 11 received endo-
vascular therapy. True lumen residual diameter in the observation group (46.6%) was statistically better than that in the
surgery group (0%) and the endovascular group (18.3%) (P < .05). There was clinical progression in three and imaging
progression in seven of the observation group, of which two patients received endovascular treatment and one patient
died of bowel infarction. There were two clinical progressions and one imaging progression in the surgery group, of which
two patients received additional surgery and one patient died of bowel infarction. The endovascular group obtained
encouraging results with no progressions or complications.
Conclusions: Symptomatic patients with SIDSMA are at risk of progression. We suggested a morphologic classiﬁcation to
guide the treatment. We recommend observation treatment with close follow-up for patients with patent true lumen ﬂow
and endovascular intervention for high-risk patients with true lumen stenosis or occlusion. Surgery is indicated for
patients with suspected bowel infarction or arterial rupture. (J Vasc Surg 2014;59:165-72.)Spontaneous isolated dissection of the superior mesen-
teric artery (SIDSMA), without associated aortic dissection,
is regarded as a clinically rare disease. This acute disorder
often manifests as acute abdomen. However, its natural
history and prognosis are reported without uniform results.
It may either regress with no symptoms, or progress to
occlusion of the superior mesenteric artery (SMA) or a dis-
secting aneurysm with the risk of bowel ischemia or arterial
rupture.1-3 Different treatment options have been reported
to manage SIDSMA, including observation therapy, open
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://dx.doi.org/10.1016/j.jvs.2013.07.014optimal initial treatment remains controversial. Cho et al
suggested observation treatment with anticoagulation for
SIDSMA if there is no bowel infarction or bleeding.4 Chu
et al held that observation therapy did not necessarily
prevent the progression of SIDSMA and, instead, recom-
mended early endovascular intervention before the onset
of fatal complications.6
On the other hand, as with the aortic dissection,
patients with SIDSMA may have different types of dissec-
tions, progress with different results, and require different
management. The classiﬁcation of SIDSMA types, thus,
appears to be important for treatment. However, there is
no uniform categorization of SIDSMA. Sakamoto and
other researchers have described different classiﬁcations,
but none of them has provided strong guidance on treat-
ment options. Sakamoto et al7 categorized SIDSMA into
four types based on the patency of the false lumen: type
I, patent false lumen with both entry and re-entry; type
II, “cul-de-sac”-shaped false lumen without re-entry;
type III, thrombosed false lumen with an ulcer-like projec-
tion (ULP); and type IV, completely thrombosed false
lumen without an ULP. Yun et al3 reported another cate-
gorization, which is similar to Sakamoto’s classiﬁcation,
only adding the type of “total occlusion of SMA.” Both
of the classiﬁcations do not include the type of “dissecting
aneurysm” that is often seen in SIDSMA patients.8 Zerbib
et al9 described a modiﬁed Sakamoto’s classiﬁcation add-
ing the type of “dissecting aneurysm” and the type of165
Fig 1. Morphologic classiﬁcation of spontaneous isolated dissection of the superior mesenteric artery (SIDSMA).
Type I, patent false lumen with both entry and re-entry; type II, “cul-de-sac” shaped false lumen without re-entry
(subdivided into IIa, patent true lumen; IIb, severe stenosis of the true lumen; and IIc, occlusion of the true
lumen); type III, thrombosed false lumen with an ulcer-like projection (ULP) (subdivided into IIIa, patent true lumen;
IIIb, severe stenosis of the true lumen; and IIIc, occlusion of the true lumen); type IV, completely thrombosed false
lumen without an ULP (subdivided into IVa, patent true lumen; IVb, severe stenosis of the true lumen; and IVc,
occlusion of the true lumen); and type V, dissecting aneurysm.
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SIDSMA into two types: (1) double lumen with patent
or closed false lumen and (2) intramural hematoma with
or without stenosis. The Sakamoto classiﬁcation does not
take into consideration the patency of the true lumen,
which is valuable for evaluation of the mesenteric blood
supply and decision of the treatment strategy. The other
three classiﬁcations consider the SMA patency but do not
cover the full aspects of the morphologic ﬁndings of
patients with SIDSMA. In this study, we report our
management experience of 42 consecutive patients with
SIDSMA and their follow-up to explore a therapy strategy
based on a new morphologic classiﬁcation.
METHODS
Study population. The retrospective study included
42 consecutive patients with symptomatic SIDSMA in
our department between January 2007 and December
2012. The protocol was approved by the Institutional
Review Board from the Ethics Committee of Zhejiang
University. All of the patients presented with acute onsetabdominal pain. The diagnosis of SIDSMA was made
according to spiral computed tomography (CT) angiog-
raphy ﬁndings, such as an intimal ﬂap in the SMA and/
or thrombosis of the false lumen. Patients with concomi-
tant aortic dissection or recent abdominal trauma were
excluded from the study.
Deﬁnition and measures. We retrospectively reviewed
the clinical features, risk factors, CT images, treatment
modalities, follow-up results, and prognosis of the
42 patients. Imaging characteristics such as morphologic
classiﬁcation, location of entry site, dissection length, true
lumen residual diameter (TLRD) (true lumen size
compared with adjacent normal SMA size), and aneurysmal
dilatation were analyzed from the CT angiographic
pictures.
We propose a modiﬁed morphologic classiﬁcation with
subtypes (Fig 1): type I, patent false lumen with both entry
and re-entry; type II, “cul-de-sac”-shaped false lumen
without re-entry (subdivided into IIa, patent true lumen;
IIb, severe stenosis of the true lumen; and IIc, occlusion
of the true lumen); type III, thrombosed false lumen
Fig 2. Entry site classiﬁcation of spontaneous isolated dissection
of the superior mesenteric artery (SIDSMA): zone 1, from oriﬁce
to 1 cm proximal to the SMA curvature; zone 2, from 1 cm
proximal to 1 cm distal to the SMA curvature; and zone 3, from
distal to 1 cm distal to the SMA curvature. Number of patients in
each zone from this study: six patients in zone 1, 27 patients in
zone 2, and nine patients in zone 3. pts, Patients.
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IIIb, severe stenosis of the true lumen; and IIIc, occlusion
of the true lumen); type IV, completely thrombosed false
lumen without an ULP (subdivided into IVa, patent true
lumen; IVb, severe stenosis of the true lumen; and IVc,
occlusion of the true lumen); and type V, dissecting aneu-
rysm. The subtypes of a, b, and c were determined by
TLRD, and the values of TLRD for subdivision were to
be explored by this study. A dissecting aneurysm of the
SMA was deﬁned as an increase in diameter of more than
50% compared with the normal part of the SMA.8 We
recorded TLRD of every patient based on CT measure-
ments. The dissection entry sites were categorized into
three zones: zone 1, from oriﬁce to 1 cm proximal to the
SMA curvature; zone 2, from 1 cm proximal to 1 cm distal
to the SMA curvature; and zone 3, from distal to 1 cm
distal to the SMA curvature (Fig 2).3
Treatment options. The choice of treatment was
decided on the basis of the patients’ symptoms and signs
and the morphologic characteristics from the CT ﬁndings.
Patients with the following characteristics were indicated
for surgical or endovascular intervention: (1) signs of
bowel infarction, (2) signs of arterial rupture, (3) persistent
abdominal pain not relieved by observation treatment, (4)
severe compression or occlusion of the true lumen, and (5)
aneurysmal dilation of the SMA. Observation treatment
included blood pressure control, bowel rest, and parenteral
nutritional support without anticoagulation or antiplatelet
agents. Surgical intervention consisted of SMA thrombec-
tomy, infarcted bowel resection, and distal aortomesenteric
bypass. Endovascular intervention included self-
expandable stent placement in the true lumen, thrombo-
lytic therapy through intubation tube in the thrombosed
SMA, and coil embolization of the pseudoaneurysm in the
dissected SMA. Patients undergoing surgical SMA repair
or endovascular stenting received antiplatelet drugs for
6 months postoperatively.
Statistical analysis. Statistical analysis was conducted
using c2 test and one-way analysis of variance test with
the SPSS software (15.0 v; SPSS Inc, Chicago, Ill). P values
of <.05 were considered statistically signiﬁcant.
RESULTS
Patient characteristics. The study involved 39 men
and three women, with ages ranging from 33 to 80 years
(median age 55 years). All of the patients suffered from
acute abdominal pain. The demographics of the patients
are shown in Table I. Hypertension was detected in 14/
42 patients, hyperlipidemia in 7/42 patients, and cigarette
smoking in 26/42 patients. None of the patients was
diagnosed with ﬁbromuscular dysplasia, cystic medial
necrosis, or diseases of the elastic tissue. The dissections
had a mean length of 7.1 cm (range, 2.5-14.6 cm) with
a mean entry site distance of 2.4 cm (range, 0.5-5 cm) from
the oriﬁce of the SMA.
Treatment. Twenty-four patients received only observa-
tion treatment initially, whereas the other 18 patients under-
went surgical laparotomy (seven patients) or endovascularintervention (11 patients) (Table I). Two patients in the
observation group received endovascular coil embolization
of a pseudoaneurysm and stenting in the true lumen
because of a dissecting aneurysm and abdominal pain
3 months and 30 months after initial medical treatment,
respectively (Fig 3). Surgical intervention consisted of SMA
Table I. Demographics and computed tomography (CT) appearances of patients with spontaneous isolated dissection of
the superior mesenteric artery (SIDSMA)
Observation group
(n ¼ 24)
Surgical group
(n ¼ 7)
Endovascular group
(n ¼ 11) Pa
Median age, years (range) 50.5 (33-71)b 58 (41-80)b 58 (46-69) .021
Male 24b 5b 10 .034
Mean days before admission (range) 4.8 (1-15) 4.0 (1-15) 6.4 (1-30) .663
Mean diagnosis delay, days (range) 2.2 (0-12) 2.1 (0-10) 5.0 (0-30) .371
CT appearances
Mean TLRDd (range) 46.6% (20%-71%)b 0b 18.3% (0-49%)b .000
Classiﬁcation (range of TLRD) .002
I 8 (22%-59%)b 0 0b
II 1 (36%) 0 3 (0-27%)
III 4 (36%-57%) 3 (0) 4 (0-27%)
IV 11 (20%-71%) 4 (0) 1 (0)
V 0 0 3 (32%-49%)
Entry site zone .770
Zone 1 3 2 1
Zone 2 15 4 8
Zone 3 6 1 2
Mean hospital stay, days (range) 9.3 (3-27) 19.4 (6-32)c 11.0 (7-17) .018
TLRD, True lumen residual diameter.
aP value of <.05 was considered statistically signiﬁcant.
bThere was statistical difference between the two groups with marks.
cThere was statistical difference between the marked group and any one of the other two groups.
dDiameter of the true lumen compared with that of adjacent normal SMA.
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(three patients), and distal aortomesenteric bypass (one
patient). Endovascular intervention included self-
expandable bare stent placement (10 patients) and tube
thrombolysis in the thrombosed SMA (one patient). Self-
expandable stents (S.M.A.R.T.; Cordis, Miami Lakes, Fla;
Xpert; Abbott Vascular, Abbott Park, Ill; Astron Pulsar;
Biotronik AG, Switzerland) with diameters of up to 8 mm
and overall lengths of up to 60 mm were used.
The surgical group was older (61.4 years old) and had
fewer males (5/7) than the observation group (51.2 years
old, 24/24 male). Furthermore, the surgical group had
a longer hospital stay (19.4 days) than the observation
group (9.3 days) and the endovascular group (11.0 days)
(Table I).
TLRD and morphologic classiﬁcation. TLRD in the
observation group (46.6%) was better than that in the
endovascular group (18.3%) and the surgery group (0%).
There was statistical difference between each two groups.
Furthermore, as shown in Table I, regarding types II,
III, and IV, TLRD in the observation group was >30%
(range, 35%-71%), and in the surgical group and the
endovascular group was <30% (range, 0-27%), except for
one observation patient with TLRD of 20% who later died
of bowel infarction. We, thus, suggest a subtype classiﬁ-
cation depending on whether TLRD is $30%: subtype a,
patent true lumen with TLRD $30%; subtype b, severe
stenosis of the true lumen with TLRD <30%; subtype c,
occlusion of the true lumen with TLRD ¼ 0. The new
morphologic classiﬁcation of patients in each group is
summarized in Table II.Follow-up. Follow-up involved an assessment of
abdominal symptoms and CT scan at 1 month, 6 months,
and yearly thereafter. The median time of follow-up was
23 months (until March 2013), with a range of 6 to 68
months. The results for the patients are shown in Table III.
The observation group had more morphologic progres-
sions (7/24) than the endovascular group (0/11). There
were more total deaths (4/7) in the surgical group than in
the observation group (1/24) and the endovascular group
(0/11).
There were three clinical progressions with abdominal
pain recurrence in the observation group, of which two
patients received endovascular therapy because of a dissect-
ing aneurysm (Fig 3), and one patient died of bowel infarc-
tion. The other 21 patients in the observation group
remained asymptomatic during follow-up. The CT scans
showed no change in ﬁve patients, improved stenosis with
hematoma regression in 12 patients, aneurysmal changes
in six patients, and true lumen occlusion in one patient.
Two patients showed recurrent abdominal pain after
surgical repair, of which one patient received endovascu-
lar tube thrombolysis in the SMA after thrombectomy,
and the other died of remaining bowel infarction after
thrombectomy and bowel resection. There were three
unrelated deaths: a patient died of trauma a year after
a surgical bypass of the SMA, another patient died
from a stroke 8 months after SMA thrombectomy, and
another died from cardiac infarction 9 months after
a bowel resection.
The patients in the endovascular group stayed asymp-
tomatic during the follow-up period, and CT scans
Fig 3. A 68-year-old man with type IIa spontaneous isolated dissection of the superior mesenteric artery (SIDSMA).
Computed tomography (CT) scans (A) demonstrated patent true lumen and observation treatment was applied.
The false lumen progressed to a pseudoaneurysm (B) 30 months later, and the patient received endovascular coil
embolization and stenting (C, D).
Table II. Morphologic classiﬁcation
Morphologic
classiﬁcation
with subtypes
Observation
group
Surgical
group
Endovascular
group Total
I 8 0 0 8
IIa 1 0 0 1
IIb 0 0 1 1
IIc 0 0 2 2
IIIa 4 0 0 4
IIIb 0 0 2 2
IIIc 0 3 2 5
IVa 10 0 0 10
IVb 1 0 0 1
IVc 0 4 1 5
V 0 0 3 3
Total 24 7 11 42
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tion of the false lumen, reduced aneurysm size, and
improved remodeling (Fig 4). No operation-related
complications were observed.DISCUSSION
SIDSMA is a rare vascular disease that has been increas-
ingly identiﬁed recently due to advances in imaging tech-
nology.11-14 Compared with the aortic dissection, which
is more common and widely studied,15,16 the underlying
cause of SIDSMA has not been well clariﬁed. Besides arte-
riosclerosis, ﬁbromuscular dysplasia, cystic medial necrosis,
and diseases of the elastic tissue, which have been
mentioned in the literature as possible causes of
SIDSMA,17 Park et al suggested hemodynamic force
induced by convex curvature as another possible
etiology.18 In this study, we found that SIDSMA was
more common in men (92.9% [39/42] vs 71.1%), more
frequent with smoking (61.9% [26/42] vs 39.5%), and
less frequent with hypertension (33.3% [14/42] vs
65.8%) compared with combined aortic and superior
mesenteric artery dissection from Park’s report.18
The natural history of SIDSMA has not been fully
recognized, which is important for the option of treatment
measures. Park et al found morphologic improvement in
Table III. Follow-up of patients with spontaneous isolated dissection of the superior mesenteric artery (SIDSMA)
Observation group
(n ¼ 24)
Surgical group
(n ¼ 7)
Endovascular group
(n ¼ 11) Pa
Mean follow-up time, months (range) 23 (10-57) 28 (9-68) 20 (6-48) .972
CT appearances .036
Improved 12 6 11
Unchanged 5 0 0
Progression 7b 1 0b
Abdominal pain recurrence 3 2 0 .187
Related death 1 1 0 .374
Total death 1 4c 0 .000
CT, Computed tomography.
aP value of <.05 was considered statistically signiﬁcant.
bThere was statistical difference between the two groups with marks.
cThere was statistical difference between the marked group and any one of the other two groups.
Fig 4. A 48-year-old man with type IIb spontaneous isolated dissection of the superior mesenteric artery (SIDSMA).
Computed tomography (CT) scans (A) and angiography (B) demonstrated the true lumen with severe stenosis and the
false lumen without re-entry sites. Follow-up CT scans after endovascular stenting revealed patent stent with gradual
resolution of the false lumen (C, 3 months postoperation; D, 12 months postoperation).
JOURNAL OF VASCULAR SURGERY
170 Li et al January 201441.3% (19/46) of patients, complete remodeling in 15.2%
(7/46) of patients, and no dissection progression on CT
follow-up after observation treatment.18 Although 26.3%
(10/46) of the patients presented with mild abdominaldiscomfort, none of them developed recurrent abdominal
pain, and no related mortality was observed. The literature
review by Gobble et al identiﬁed 106 cases of SIDSMA and
demonstrated a failure rate of 44.6% (25/56) in the
Fig 5. Management strategy based on clinical manifestation and
morphologic classiﬁcation for patients with symptomatic sponta-
neous isolated dissection of the superior mesenteric artery
(SIDSMA). CT, Computed tomography.
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coagulation group.2 In the two observation groups,
17.7% (14/79) patients died because of treatment failure.
The authors therefore recommended primary endovascular
stenting for symptomatic SIDSMA patients. Of the patients
in the observation group, our study observed morphologic
progressions on the CT images in 29.2% (7/24), clinical
progressions with abdominal pain recurrence in 12.5%
(3/24), and a 4.2% (1/24) mortality rate. This outcome
reminds us that the SIDSMA has the potential to progress
and may cause fatal complications.
There is no consensus on the best treatment for this
potentially fatal disease, and the management strategy has
not yet been established. Treatment of SIDSMA can be
classiﬁed into observation management, open surgery,
and endovascular therapy. Observation management
includes bowel rest and parenteral nutritional support
with or without anticoagulation.3,4 Open surgery was
more frequently performed in the early days for patients
with unrelieved abdominal pain, especially for those with
signs of bowel infarction or arterial rupture.19-21 The rapid
development of percutaneous endovascular intervention
has resulted in the wide use of this technique for vascular
diseases. Endovascular therapy is a less invasive treatment
alternative with high procedural success and a low perio-
perative morbidity compared with open repair, and the
number of successful reports of its use has increased in
recent years.2,6,22-24 Our study identiﬁed that the endovas-
cular group had a shorter hospital stay (11.0 vs 19.4 days)
and a lower total mortality rate (0/11 vs 4/7) than the
surgical group.
Sakamoto et al7 categorized SIDSMA into four types
based on the patency of the false lumen, a typology that
is often referred to in the literature. However, this classiﬁ-
cation does not take into consideration the patency of the
true lumen, which is valuable for the evaluation of the
mesenteric blood supply. It therefore has not established
a clear relationship between morphologic appearance and
clinical course. Our study identiﬁed that TLRD in the
observation group (46.6%) was statistically better than
that in the endovascular group (18.3%) and the surgery
group (0%). Although the difference of TLRD between
groups was due to selection bias in this retrospective study,
these results indicated that the TLRD may serve as an
instrument for deciding on a treatment algorithm. If the
true lumen is patent for the mesenteric blood supply,
then abdominal pain will be relieved and observation
measures might work. If there is severe stenosis or occlu-
sion in the true lumen, then bowel ischemia could appear
and surgical or endovascular intervention would be
necessary.
In our proposed classiﬁcation, type I SIDSMA has
patent false and true lumen, and there is usually no severe
bowel ischemia. The follow-up of the type I patients in our
study showed that 3/8 progressed to dissecting aneurysms.
We suggest initial observation treatment for type I patients
with close follow-up because of the risk of dissecting
aneurysm formation. Furthermore, true lumen stenosis intype IIa, IIIa, and IVa patients is relatively less severe,
and thus, the symptoms usually resolve under observation
treatment. The follow-up of type IIa, IIIa, and IVa
patients in this study found that 12/15 of the patients
recovered smoothly without progression. We, thus, also
suggest initial observation treatment for type IIa, IIIa,
and IVa patients. Severe stenosis (types IIb, IIIb, and
IVb) and occlusion (types IIc, IIIc, and IVc) of the true
lumen often induce bowel ischemia, and additional inter-
ventions besides medication are often needed. We suggest
endovascular therapy as the preferential intervention for
“b” and “c” subtype SIDSMA for its low invasiveness
and mortality rate. If endovascular treatment fails or there
are signs of bowel infarction or arterial rupture, then open
surgery is indicated. Eventually, a dissecting aneurysm in
type V patients will compress the true lumen and increase
the risk of arterial rupture. We, thus, propose early endo-
vascular intervention such as coil embolization and
stenting for such patients. In brief, we recommend
a personalized management strategy based on the patient’s
clinical manifestations and our morphologic classiﬁcation
(Fig 5).
Our study has some limitations. First, it was a retrospec-
tive review and the grouping of the patients was not
randomized. The differences such as TLRD, hospital stay,
and total mortality rate between groups might be the
results of selection bias. Second, the number of patients
involved in the study was relatively small, and the follow-
up was relatively short. The natural history of SIDSMA
and the prognosis of endovascular stents should be
observed over a longer period. Prospectively randomized
clinical studies with a large number of cases and long-
term follow-up are needed to validate the treatment
strategy.
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SIDSMA is a rare disease with different natural histo-
ries and without a uniform classiﬁcation, and the manage-
ment strategy for the disease remains controversial. Our
observations illustrate that symptomatic SIDSMA carries
a risk of progression with a potential trend of bowel infarc-
tion. Based on our morphologic classiﬁcation, we suggest
close observation with medical management in stable
patients with SIDSMA with patent true lumen ﬂow (types
I, IIa, IIIa, and IVa), and endovascular repair in cases of
true lumen stenosis and occlusion (types IIb, IIc, IIIb,
IIIc, IVb, IVc, and V). Surgery might be necessary if the
endovascular therapy fails or there are signs of bowel infarc-
tion or arterial rupture. A personalized management
strategy based on clinical and morphologic characteristics
should, thus, be considered and evaluated in the future.
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